| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by operating activities | -24 | -73 |
| Purchases of property and equipment | 40 | 37 |
| Net cash used in investing activities | -40 | -37 |
| Payments on related party note payable | 200 | 200 |
| Net cash used in financing activities | -200 | -200 |
| Net decrease in cash | -264 | -310 |
| Cash and cash equivalents at beginning of period | 1,230 | - |
| Cash and cash equivalents at end of period | 966 | - |
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)